Deka Bank Deutsche Girozentrale Galapagos Nv Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$47.03 - $57.12 $129,802 - $157,651	-2,760 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$122.47 - $213.56 $338,017 - $589,425	2,760 New	2,760 $379,000
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $730,464 - $1.05 Million	-5,600 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$111.45 - $128.93 $66,870 - $77,358	-600 Reduced 9.68%	5,600 $714,000
Q1 2019 May 10, 2019	BUY	$89.61 - $117.78 $304,674 - $400,452	3,400 Added 121.43%	6,200 $632,000
Q4 2018 Feb 12, 2019	SELL	$87.81 - $110.65 $298,554 - $376,210	-3,400 Reduced 54.84%	2,800 $247,000
Q3 2018 Nov 09, 2018	SELL	$90.63 - $120.22 $13,594 - $18,033	-150 Reduced 2.36%	6,200 $0
Q1 2018 May 03, 2018	BUY	$94.51 - $120.23 $600,138 - $763,460	6,350 New	6,350 $636,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.